$ENTA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENANTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENANTA PHARMACEUTICALS INC. Get notifications about new insider transactions in ENANTA PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 05 2017 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 35.09 | 13,921 | 488,505 | 301,876 | 315.8 K to 301.9 K (-4.41 %) |
Nov 30 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 31.44 | 13,921 | 437,609 | 315,797 | 329.7 K to 315.8 K (-4.22 %) |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 30.00 | 25,000 | 750,000 | 25,000 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 30.00 | 35,000 | 1,050,000 | 35,000 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Option Exercise | A | 30.00 | 25,000 | 750,000 | 25,000 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 30.00 | 30,000 | 900,000 | 30,000 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 30.00 | 35,000 | 1,050,000 | 35,000 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 30.00 | 120,000 | 3,600,000 | 120,000 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Russell Lesley | Director | Option Exercise | A | 30.00 | 10,000 | 300,000 | 10,000 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Russell Lesley | Director | Option Exercise | A | 30.00 | 10,000 | 300,000 | 10,000 | |
Sep 29 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 14.00 | 3,478 | 48,692 | 3,478 | |
Sep 29 2016 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 14.00 | 3,478 | 48,692 | 3,478 | |
Sep 29 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 14.00 | 6,957 | 97,398 | 6,957 | |
Jul 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 14.00 | 3,484 | 48,776 | 3,484 | |
Jul 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 14.00 | 3,484 | 48,776 | 3,484 | |
Jul 22 2016 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 14.00 | 3,484 | 48,776 | 3,484 | |
Jul 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 14.00 | 6,967 | 97,538 | 6,967 | |
Jun 13 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 2.97 | 41,645 | 123,848 | 0 | |
Jun 13 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 2.97 | 41,645 | 123,848 | 630,299 | 588.7 K to 630.3 K (+7.07 %) |
May 12 2016 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | P | 24.45 | 500 | 12,223 | 1,900 | 1.4 K to 1.9 K (+35.71 %) |
May 10 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 2.97 | 25,000 | 74,348 | 41,645 | |
May 10 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 2.97 | 25,000 | 74,348 | 588,654 | 563.7 K to 588.7 K (+4.44 %) |
Mar 09 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 2.54 | 18,561 | 47,199 | 0 | |
Mar 09 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 2.54 | 18,561 | 47,199 | 563,654 | 545.1 K to 563.7 K (+3.41 %) |
Feb 29 2016 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | M | 1.29 | 6,689 | 8,649 | 0 | |
Feb 29 2016 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Buy | M | 1.29 | 6,689 | 8,649 | 67,086 | 60.4 K to 67.1 K (+11.08 %) |
Feb 17 2016 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Buy | P | 27.04 | 2,000 | 54,080 | 15,295 | 13.3 K to 15.3 K (+15.04 %) |
Feb 12 2016 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 25.58 | 6,000 | 153,480 | 6,000 | |
Feb 12 2016 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 25.58 | 6,000 | 153,480 | 6,000 | |
Feb 12 2016 | ENTA | ENANTA PHARMACEUTI ... | Buckley Stephen Jr. | Director | Option Exercise | A | 25.58 | 6,000 | 153,480 | 6,000 | |
Feb 12 2016 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Option Exercise | A | 25.58 | 6,000 | 153,480 | 6,000 | |
Feb 12 2016 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | A | 25.58 | 6,000 | 153,480 | 6,000 | |
Jan 20 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 2.54 | 23,201 | 58,998 | 0 | |
Jan 20 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 2.54 | 5,800 | 14,749 | 0 | |
Jan 20 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 2.54 | 13,921 | 35,400 | 0 | |
Jan 20 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 2.54 | 23,201 | 58,998 | 329,718 | 306.5 K to 329.7 K (+7.57 %) |
Jan 20 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 2.54 | 5,800 | 14,749 | 306,517 | 300.7 K to 306.5 K (+1.93 %) |
Jan 20 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 2.54 | 13,921 | 35,400 | 300,717 | 286.8 K to 300.7 K (+4.85 %) |
Jan 11 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 14.00 | 3,478 | 48,692 | 3,478 | |
Jan 11 2016 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 14.00 | 3,478 | 48,692 | 3,478 | |
Jan 11 2016 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 14.00 | 6,957 | 97,398 | 6,957 | |
Jan 05 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 1.51 | 13,921 | 21,000 | 0 | |
Jan 05 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 1.98 | 13,921 | 27,600 | 0 | |
Jan 05 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 2.97 | 50,723 | 150,845 | 0 | |
Jan 05 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 1.51 | 13,921 | 21,000 | 286,796 | 272.9 K to 286.8 K (+5.10 %) |
Jan 05 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 1.98 | 13,921 | 27,600 | 272,875 | 259 K to 272.9 K (+5.38 %) |
Jan 05 2016 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 2.97 | 50,723 | 150,845 | 258,954 | 208.2 K to 259 K (+24.36 %) |
Nov 25 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 32.29 | 1 | 32 | 54,397 | 54.4 K to 54.4 K (0.00 %) |
Nov 25 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 31.26 | 100 | 3,126 | 54,398 | 54.5 K to 54.4 K (-0.18 %) |
Nov 25 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 30.13 | 5,899 | 177,763 | 54,498 | 60.4 K to 54.5 K (-9.77 %) |
Nov 24 2015 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Option Exercise | A | 31.42 | 25,500 | 801,210 | 25,500 | |
Nov 24 2015 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 31.42 | 25,500 | 801,210 | 25,500 | |
Nov 24 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 31.42 | 30,000 | 942,600 | 30,000 | |
Nov 24 2015 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 31.42 | 16,000 | 502,720 | 16,000 | |
Nov 24 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 31.42 | 33,000 | 1,036,860 | 33,000 | |
Nov 24 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 31.42 | 110,000 | 3,456,200 | 110,000 | |
Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 1.21 | 9,280 | 11,199 | 0 | |
Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 1.51 | 18,561 | 27,999 | 0 | |
Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 1.98 | 18,561 | 36,799 | 0 | |
Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 1.29 | 22,298 | 28,831 | 0 | |
Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 1.21 | 9,280 | 11,199 | 545,093 | 535.8 K to 545.1 K (+1.73 %) |
Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 1.51 | 18,561 | 27,999 | 535,813 | 517.3 K to 535.8 K (+3.59 %) |
Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 1.98 | 18,561 | 36,799 | 517,252 | 498.7 K to 517.3 K (+3.72 %) |
Oct 23 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 1.29 | 22,298 | 28,831 | 498,691 | 476.4 K to 498.7 K (+4.68 %) |
Oct 16 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 40.10 | 7,500 | 300,743 | 60,397 | 67.9 K to 60.4 K (-11.05 %) |
Sep 10 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 40.06 | 708 | 28,362 | 67,897 | 68.6 K to 67.9 K (-1.03 %) |
Sep 10 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 39.50 | 6,792 | 268,291 | 68,605 | 75.4 K to 68.6 K (-9.01 %) |
Aug 11 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 43.35 | 1,600 | 69,367 | 208,231 | 209.8 K to 208.2 K (-0.76 %) |
Aug 11 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 42.57 | 2,150 | 91,516 | 209,831 | 212 K to 209.8 K (-1.01 %) |
Aug 10 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 45.35 | 200 | 9,069 | 75,397 | 75.6 K to 75.4 K (-0.26 %) |
Aug 10 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 43.80 | 1,100 | 48,181 | 75,597 | 76.7 K to 75.6 K (-1.43 %) |
Aug 10 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 42.60 | 6,200 | 264,139 | 76,697 | 82.9 K to 76.7 K (-7.48 %) |
Jul 14 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 46.55 | 1,587 | 73,868 | 82,897 | 84.5 K to 82.9 K (-1.88 %) |
Jul 14 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 46.23 | 5,913 | 273,338 | 84,484 | 90.4 K to 84.5 K (-6.54 %) |
Jul 14 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 46.56 | 630 | 29,334 | 211,981 | 212.6 K to 212 K (-0.30 %) |
Jul 14 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 46.24 | 3,120 | 144,261 | 212,611 | 215.7 K to 212.6 K (-1.45 %) |
Jul 01 2015 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 43.46 | 90,000 | 3,911,400 | 90,000 | |
Jun 15 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 42.47 | 3,750 | 159,265 | 215,731 | 219.5 K to 215.7 K (-1.71 %) |
Jun 12 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 42.51 | 7,500 | 318,812 | 90,397 | 97.9 K to 90.4 K (-7.66 %) |
Jun 08 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 42.02 | 10,750 | 451,662 | 219,481 | 230.2 K to 219.5 K (-4.67 %) |
May 20 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 40.13 | 24,000 | 963,094 | 97,897 | 121.9 K to 97.9 K (-19.69 %) |
May 12 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 36.13 | 8,000 | 289,045 | 230,231 | 238.2 K to 230.2 K (-3.36 %) |
Mar 10 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 34.88 | 100 | 3,488 | 476,393 | 476.5 K to 476.4 K (-0.02 %) |
Mar 10 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 34.07 | 3,600 | 122,658 | 476,493 | 480.1 K to 476.5 K (-0.75 %) |
Mar 10 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 33.13 | 11,300 | 374,375 | 480,093 | 491.4 K to 480.1 K (-2.30 %) |
Feb 20 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 35.35 | 15,000 | 530,289 | 491,393 | 506.4 K to 491.4 K (-2.96 %) |
Feb 20 2015 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 33.65 | 6,000 | 201,900 | 6,000 | |
Feb 20 2015 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 33.65 | 6,000 | 201,900 | 6,000 | |
Feb 20 2015 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | A | 33.65 | 6,000 | 201,900 | 6,000 | |
Feb 20 2015 | ENTA | ENANTA PHARMACEUTI ... | Buckley Stephen Jr. | Director | Option Exercise | A | 33.65 | 6,000 | 201,900 | 6,000 | |
Feb 20 2015 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Option Exercise | A | 33.65 | 6,000 | 201,900 | 6,000 | |
Feb 19 2015 | ENTA | ENANTA PHARMACEUTI ... | Buckley Stephen Jr. | Director | Buy | P | 34.20 | 600 | 20,520 | 2,000 | 1.4 K to 2 K (+42.86 %) |
Feb 19 2015 | ENTA | ENANTA PHARMACEUTI ... | Buckley Stephen Jr. | Director | Buy | P | 33.69 | 400 | 13,476 | 1,400 | 1,000 to 1.4 K (+40.00 %) |
Feb 17 2015 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | P | 33.10 | 400 | 13,240 | 1,400 | 1,000 to 1.4 K (+40.00 %) |
Feb 17 2015 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | P | 33.47 | 600 | 20,082 | 1,000 | 400 to 1,000 (+150.00 %) |
Feb 17 2015 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | P | 33.00 | 400 | 13,200 | 400 | 0 to 400 |
Jan 20 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 49.85 | 1,920 | 95,705 | 121,897 | 123.8 K to 121.9 K (-1.55 %) |
Jan 20 2015 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 49.15 | 2,580 | 126,800 | 123,817 | 126.4 K to 123.8 K (-2.04 %) |
Jan 06 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 1.21 | 51,044 | 61,600 | 0 | |
Jan 06 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 1.21 | 6,960 | 8,399 | 0 | |
Jan 06 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 1.21 | 51,044 | 61,600 | 238,231 | 187.2 K to 238.2 K (+27.27 %) |
Jan 06 2015 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 1.21 | 6,960 | 8,399 | 187,187 | 180.2 K to 187.2 K (+3.86 %) |
Jan 06 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 50.97 | 4,000 | 203,894 | 506,393 | 510.4 K to 506.4 K (-0.78 %) |
Jan 06 2015 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 50.23 | 11,000 | 552,569 | 510,393 | 521.4 K to 510.4 K (-2.11 %) |
Dec 15 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.73 | 7,055 | 5,169 | 0 | |
Dec 15 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.73 | 7,055 | 5,169 | 521,393 | 514.3 K to 521.4 K (+1.37 %) |
Dec 02 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 48.57 | 842 | 40,895 | 126,397 | 127.2 K to 126.4 K (-0.66 %) |
Dec 02 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 48.12 | 850 | 40,903 | 127,239 | 128.1 K to 127.2 K (-0.66 %) |
Dec 02 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 46.91 | 4,308 | 202,086 | 128,089 | 132.4 K to 128.1 K (-3.25 %) |
Dec 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 46.97 | 2,400 | 112,727 | 514,338 | 516.7 K to 514.3 K (-0.46 %) |
Dec 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 45.96 | 1,200 | 55,152 | 516,738 | 517.9 K to 516.7 K (-0.23 %) |
Dec 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 44.99 | 11,400 | 512,936 | 517,938 | 529.3 K to 517.9 K (-2.15 %) |
Nov 21 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 44.00 | 36,500 | 1,606,000 | 36,500 | |
Nov 21 2014 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Option Exercise | A | 44.00 | 27,500 | 1,210,000 | 27,500 | |
Nov 21 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 44.00 | 85,250 | 3,751,000 | 85,250 | |
Nov 21 2014 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 44.00 | 27,500 | 1,210,000 | 27,500 | |
Nov 21 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 44.00 | 32,500 | 1,430,000 | 32,500 | |
Nov 04 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 43.05 | 3,223 | 138,745 | 529,338 | 532.6 K to 529.3 K (-0.61 %) |
Nov 04 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 42.38 | 11,777 | 499,067 | 532,561 | 544.3 K to 532.6 K (-2.16 %) |
Oct 22 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 46.45 | 1,716 | 79,714 | 132,397 | 134.1 K to 132.4 K (-1.28 %) |
Oct 22 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 45.64 | 1,140 | 52,035 | 134,113 | 135.3 K to 134.1 K (-0.84 %) |
Oct 22 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 43.79 | 1,144 | 50,091 | 135,253 | 136.4 K to 135.3 K (-0.84 %) |
Aug 15 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 39.13 | 10,000 | 391,283 | 146,397 | 156.4 K to 146.4 K (-6.39 %) |
Sep 16 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 40.51 | 300 | 12,154 | 136,397 | 136.7 K to 136.4 K (-0.22 %) |
Sep 16 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 39.81 | 9,700 | 386,186 | 136,697 | 146.4 K to 136.7 K (-6.63 %) |
Aug 15 2014 | ENTA | ENANTA PHARMACEUTI ... | Buckley Stephen Jr. | Director | Buy | P | 38.95 | 1,000 | 38,950 | 1,000 | 0 to 1,000 |
Aug 15 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 40.04 | 100 | 4,004 | 180,227 | 180.3 K to 180.2 K (-0.06 %) |
Aug 15 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 39.48 | 4,900 | 193,437 | 180,327 | 185.2 K to 180.3 K (-2.65 %) |
Aug 06 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 1.29 | 11,149 | 14,416 | 0 | |
Aug 06 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 1.29 | 11,149 | 14,416 | 185,227 | 174.1 K to 185.2 K (+6.40 %) |
Jul 16 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 40.51 | 2,149 | 87,057 | 156,397 | 158.5 K to 156.4 K (-1.36 %) |
Jul 16 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 39.81 | 17,851 | 710,600 | 158,546 | 176.4 K to 158.5 K (-10.12 %) |
Jul 03 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 42.98 | 300 | 12,893 | 174,078 | 174.4 K to 174.1 K (-0.17 %) |
Jul 03 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 42.20 | 4,700 | 198,325 | 174,378 | 179.1 K to 174.4 K (-2.62 %) |
Jun 04 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 38.14 | 1,201 | 45,801 | 179,078 | 180.3 K to 179.1 K (-0.67 %) |
Jun 04 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 37.38 | 3,799 | 142,020 | 180,279 | 184.1 K to 180.3 K (-2.06 %) |
May 12 2014 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 34.70 | 82,500 | 2,862,750 | 82,500 | |
May 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 37.23 | 3,699 | 137,699 | 184,078 | 187.8 K to 184.1 K (-1.97 %) |
May 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 36.29 | 1,301 | 47,216 | 187,777 | 189.1 K to 187.8 K (-0.69 %) |
May 02 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 14.00 | 3,478 | 48,692 | 3,478 | |
May 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 14.00 | 3,478 | 48,692 | 3,478 | |
May 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 14.00 | 6,957 | 97,398 | 6,957 | |
Apr 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 40.71 | 500 | 20,355 | 544,338 | 544.8 K to 544.3 K (-0.09 %) |
Apr 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 40.22 | 2,200 | 88,487 | 544,838 | 547 K to 544.8 K (-0.40 %) |